Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- ZAR 87.47T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | ZAR 164.9B | ZAR 1,091.05 | 0.97% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | ZAR 139.6B | ZAR 2,013.76 | 0.22% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | ZAR 83.3B | ZAR 1,480.12 | 1.24% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | ZAR 140.4B | ZAR 2,151.25 | 0.14% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | ZAR 146.6B | ZAR 5,244.35 | 0.23% down | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | ZAR 123.5B | ZAR 886.52 | 0.39% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | ZAR 77.6B | ZAR 465.75 | 0.26% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | ZAR 101.6B | ZAR 5,079.28 | 0.33% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | ZAR 153.8B | ZAR 1,619.86 | 0.21% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | ZAR 134.1B | ZAR 798.04 | 1.90% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | ZAR 76.4B | ZAR 697.50 | 3.71% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | ZAR 259.6B | ZAR 1,332.45 | 0.69% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | ZAR 79.9B | ZAR 227.79 | 4.82% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | ZAR 84.8B | ZAR 487.20 | 1.53% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | ZAR 102.5B | ZAR 1,570.07 | 0.90% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | ZAR 82.5B | ZAR 859.81 | 2.35% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | ZAR 112.3B | ZAR 1,656.13 | 0.21% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | ZAR 86.6B | ZAR 1,036.34 | 0.36% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | ZAR 165.7B | ZAR 7,132.58 | 1.91% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | ZAR 267.4B | ZAR 4,166.57 | 0.46% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | ZAR 127.6B | ZAR 1,165.66 | 3.45% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | ZAR 105.1B | ZAR 743.76 | 0.41% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | ZAR 89.9B | ZAR 2,129.81 | 1.62% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | ZAR 198.9B | ZAR 1,026.69 | 1.84% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | ZAR 67.1B | ZAR 490.04 | 3.20% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | ZAR 226.8B | ZAR 453.69 | 1.86% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | ZAR 450.2B | ZAR 2,052.27 | 2.26% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | ZAR 482.5B | ZAR 665.97 | 0.15% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | ZAR 119.4B | ZAR 2,269.89 | 3.10% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | ZAR 54B | ZAR 278.28 | 0.25% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | ZAR 129B | ZAR 1,642.43 | 0.22% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | ZAR 145.9B | ZAR 182.39 | 0.80% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | ZAR 126.4B | ZAR 1,443.76 | 2.06% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | ZAR 305.1B | ZAR 4,650.92 | 0.47% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | ZAR 420.2B | ZAR 9,867.01 | 1.96% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | ZAR 586.2B | ZAR 1,442.73 | 0.30% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | ZAR 353.4B | ZAR 2,638.72 | 2.15% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | ZAR 111.1B | ZAR 2,734.52 | 0.62% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | ZAR 128.9B | ZAR 369.99 | 1.67% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | ZAR 406B | ZAR 354.09 | 0.49% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | ZAR 215B | ZAR 257.94 | 1.22% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | ZAR 848.6B | ZAR 727.31 | 0.96% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | ZAR 2.76T | ZAR 484.10 | 1.32% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | ZAR 2.11T | ZAR 1,032.29 | 2.35% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | ZAR 677B | ZAR 1,177.38 | 0.51% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | ZAR 1.7T | ZAR 16,467.07 | 0.22% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | ZAR 2.33T | ZAR 9,190.62 | 0.15% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | ZAR 544.4B | ZAR 882.95 | 1.38% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | ZAR 792.9B | ZAR 6,941.40 | 2.52% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | ZAR 3.1T | ZAR 1,791.14 | 0.73% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | ZAR 5.92T | ZAR 2,400.43 | 2.83% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | ZAR 8.77T | ZAR 4,961.59 | 1.66% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | ZAR 100B | ZAR 146.89 | 1.22% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | ZAR 3T | ZAR 681.56 | 2.81% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | ZAR 21.3T | ZAR 23,911.96 | 1.96% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | ZAR 1.69T | ZAR 841.55 | 0.81% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | ZAR 11.4T | ZAR 4,735.35 | 1.39% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | ZAR 1.96T | ZAR 814.50 | 0.55% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | ZAR 5.09T | ZAR 2,692.82 | 1.79% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | ZAR 4.78T | ZAR 3,082.41 | 1.85% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | ZAR 1.18T | ZAR 367.88 | 1.34% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2307 ZAR).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of ZAR 87.47T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.